Laura L. Meijer

Amsterdam, NH, Netherlands

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 34 publications

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer.

Plasma miR-379 can predict treatment response to FOLFIRINOX and gemcitabine-nab-paclitaxel in advanced pancreatic cancer.

Journal: The journal of liquid biopsy

Published: February 20, 2024

In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations.

In-depth immune profiling of peripheral blood mononuclear cells in patients with pancreatic ductal adenocarcinoma reveals discriminative immune subpopulations.

Journal: Cancer science

Published: September 16, 2023

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

A bile-based microRNA signature for differentiating malignant from benign pancreaticobiliary disease.

Journal: Experimental hematology & oncology

Published: September 13, 2023

Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.

Prognostic value of microRNA-21 in intra- and extrahepatic cholangiocarcinoma after radical resection: cohort study.

Journal: BJS open

Published: September 04, 2023

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.

Prediction Model for Early-Stage Pancreatic Cancer Using Routinely Measured Blood Biomarkers.

Journal: JAMA network open

Published: August 28, 2023

Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.

Spatial immune composition of tumor microenvironment in patients with pancreatic cancer.

Journal: Cancer immunology, immunotherapy : CII

Published: August 10, 2023

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

Prognostic and predictive value of human equilibrative nucleoside transporter 1 (hENT1) in extrahepatic cholangiocarcinoma: a translational study.

Journal: Frontiers in pharmacology

Published: August 09, 2023

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.

The immune microenvironment after neoadjuvant therapy compared to upfront surgery in patients with pancreatic cancer.

Journal: Journal of cancer research and clinical oncology

Published: June 13, 2023

Crohn's disease: preserve or resect the mesentery?

Crohn's disease: preserve or resect the mesentery?

Journal: The British journal of surgery

Published: March 22, 2023

hENT1 as a Predictive Biomarker in PDAC-Letter.

hENT1 as a Predictive Biomarker in PDAC-Letter.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research

Published: December 13, 2022

Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort study.

Clinical characteristics and long-term outcomes following pancreatic injury - An international multicenter cohort study.

Journal: Heliyon

Published: September 23, 2022

Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.

Factors that influence the pancreatic and duodenal microbiome in patients undergoing pancreatic surgery.

Journal: PloS one

Published: June 26, 2022

Showing 1-12 of 34

Last Updated: 09/26/2026